These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 36916008)

  • 1. Perspectives on cutting-edge nanoparticulate drug delivery technologies based on lipids and their applications.
    Maddiboyina B; Ramaiah ; Nakkala RK; Roy H
    Chem Biol Drug Des; 2023 Aug; 102(2):377-394. PubMed ID: 36916008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration.
    Akbari J; Saeedi M; Ahmadi F; Hashemi SMH; Babaei A; Yaddollahi S; Rostamkalaei SS; Asare-Addo K; Nokhodchi A
    Pharm Dev Technol; 2022 Jun; 27(5):525-544. PubMed ID: 35635506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbohydrate anchored lipid nanoparticles.
    Kakade P; Chatterjee A; Pandya A; Disouza J; Patravale V
    Int J Pharm; 2022 Apr; 618():121681. PubMed ID: 35307469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanostructured lipid carriers for site-specific drug delivery.
    Khosa A; Reddi S; Saha RN
    Biomed Pharmacother; 2018 Jul; 103():598-613. PubMed ID: 29677547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods for preparation of nanostructured lipid carriers.
    Gomaa E; Fathi HA; Eissa NG; Elsabahy M
    Methods; 2022 Mar; 199():3-8. PubMed ID: 33992771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery.
    Kahraman E; Güngör S; Özsoy Y
    Ther Deliv; 2017 Nov; 8(11):967-985. PubMed ID: 29061106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives and Prospective on Solid Lipid Nanoparticles as Drug Delivery Systems.
    Madkhali OA
    Molecules; 2022 Feb; 27(5):. PubMed ID: 35268643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond liposomes: Recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery.
    Teixeira MC; Carbone C; Souto EB
    Prog Lipid Res; 2017 Oct; 68():1-11. PubMed ID: 28778472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-Based Nanostructures for the Delivery of Natural Antimicrobials.
    Pinilla CMB; Lopes NA; Brandelli A
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34208209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
    Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
    Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in lipid-based pharmaceutical nanocarriers.
    Musacchio T; Torchilin VP
    Front Biosci (Landmark Ed); 2011 Jan; 16(4):1388-412. PubMed ID: 21196238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicine approaches for sirolimus delivery: a review of pharmaceutical properties and preclinical studies.
    Haeri A; Osouli M; Bayat F; Alavi S; Dadashzadeh S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1-14. PubMed ID: 29186990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.
    Narang AS; Chang RK; Hussain MA
    J Pharm Sci; 2013 Nov; 102(11):3867-82. PubMed ID: 24037829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General overview of lipid-polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes.
    Wakaskar RR
    J Drug Target; 2018 Apr; 26(4):311-318. PubMed ID: 28797169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-Drug Conjugate for Enhancing Drug Delivery.
    Irby D; Du C; Li F
    Mol Pharm; 2017 May; 14(5):1325-1338. PubMed ID: 28080053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High melting lipid based approach for drug delivery: solid lipid nanoparticles.
    Kumar S; Randhawa JK
    Mater Sci Eng C Mater Biol Appl; 2013 May; 33(4):1842-52. PubMed ID: 23498204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
    Banerjee S; Pillai J
    Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery.
    Desai P; Patlolla RR; Singh M
    Mol Membr Biol; 2010 Oct; 27(7):247-59. PubMed ID: 21028936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLN, NLC, LDC: state of the art in drug and active delivery.
    Attama AA
    Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):178-87. PubMed ID: 21834777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
    Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
    Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.